嘉应制药: 半年报监事会决议公告

Group 1 - The core viewpoint of the announcement is that the Supervisory Board of Guangdong Jiaying Pharmaceutical Co., Ltd. has confirmed the authenticity and completeness of the company's 2025 semi-annual report and its summary, stating there are no false records or misleading statements [1][2]. - The Supervisory Board meeting was held on August 14, 2025, with all three attending supervisors present, and the meeting was conducted in accordance with legal and regulatory requirements [1]. - The voting results of the Supervisory Board were unanimous, with 3 votes in favor, 0 against, and 0 abstentions, indicating strong agreement on the report's accuracy [1]. Group 2 - The company disclosed the 2025 semi-annual report and its summary on the same day through the Giant Tide Information Network [1]. - The meeting was chaired by Mr. Zhong Gaohua, and some senior management personnel attended as observers [1]. - The Supervisory Board's decision reflects a commitment to transparency and accountability in financial reporting [1].